Sharon McCarthy

Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study

Kim N., Simon Chowdhury, Anders Bjartell et al. · Journal of Clinical Oncology · 2021 · 508 citations · Full text

Medicine, Oncology, Pharmacology +16

Deep, rapid, and durable prostate-specific antigen decline with apalutamide plus androgen deprivation therapy is associated with longer survival and improved clinical outcomes in TITAN patients with metastatic castration-sensitive prostate cancer

S. Chowdhury, Anders Bjartell, Neeraj Agarwal et al. · Annals of Oncology · 2023 · 113 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Efficacy and safety of trabectedin or dacarbazine in patients with advanced uterine leiomyosarcoma after failure of anthracycline-based chemotherapy: Subgroup analysis of a phase 3, randomized clinical trial

Martee L. Hensley, Shreyaskumar Patel, Margaret von Mehren et al. · Gynecologic Oncology · 2017 · 66 citations · Full text

Medicine, Oncology, Pharmacology +14

Overall survival and histology‐specific subgroup analyses from a phase 3, randomized controlled study of trabectedin or dacarbazine in patients with advanced liposarcoma or leiomyosarcoma

Shreyaskumar Patel, Margaret von Mehren, Damon R. Reed et al. · Cancer · 2019 · 65 citations · Full text

Medicine, Oncology, Pharmacology +13

Early stages of development of a peer specialist fidelity measure.

Matthew Chinman, Sharon McCarthy, Chantele Mitchell-Miland et al. · Psychiatric Rehabilitation Journal · 2016 · 63 citations · Full text

Social Sciences, Psychiatry, Clinical Psychology +10